Drug Shortage Report for ENGERIX-B

Last updated on 2018-11-30
Report ID 49681
Drug Identification Number 02296454
Brand name ENGERIX-B (PEDIATRIC DOSE)
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-16
Estimated end date Unknown
Actual end date 2018-11-29
Shortage status Resolved
Updated date 2018-11-30
Company comments
Health Canada comments
Company contact information 1-800-387-7374